Skip to Main Content

Skip Nav Destination

Article navigation

Meeting Abstracts| September 1991

Neuromuscular and cardiovascular properties of ORG9426

H. Mellinghoff, MD;

H. Mellinghoff, MD

Search for other works by this author on:

PubMed

Google Scholar

Ch. Diefenbach, MD;

Ch. Diefenbach, MD

Search for other works by this author on:

PubMed

Google Scholar

W. Buzello, MD

W. Buzello, MD

Search for other works by this author on:

PubMed

Google Scholar

Author and Article Information

Inst. of Anesthesiology, Univ. of Cologne, W-5000 Köln 41, FRG ORG9426 is a new steroidal non-depolarizing neuromuscular blocking drug currently undergoing phase-II clinical trials. Its onset of action is reported to be shorter than that of other available non-depolarizing agents¹. We wanted to establish the ED95 and study neuromuscular (nm) and cardiovascular (cv) effects of ORG9426.

Anesthesiology September 1991, Vol. 75, A807.

https://doi.org/10.1097/00000542-199109001-00806